|
|
 |
D&C RED NO. 7 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
D&C RED NO. 30 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRSUPRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRDUO DIGIHALER Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANGELIQ Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
APLENZIN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CROSCARMELLOSE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CETOSTEARYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
CELLULOSE, MICROCRYSTALLINE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|